Pentoxifylline in hepatopulmonary syndrome

World Journal of Gastroenterology

Volumn 18, Issue 35, 2012, Pages 4912-4916

  Kianifar, Hamid Reza ^a   Khalesi, Maryam ^a   Mahmoodi, Eftekhar ^a   Aghaei, Monavar Afzal ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alveolararterial oxygen gradient; Arterial oxygen pressure; Child; Hepatopulmonary syndrome; Pentoxifylline; Therapy

Indexed keywords

PENTOXIFYLLINE;

ADULT; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEPATOPULMONARY SYNDROME; HUMAN; MALE; NAUSEA; OXYGEN SATURATION; PILOT STUDY; RESPIRATORY TRACT PARAMETERS; VOMITING;

EID: 84867826624     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i35.4912     Document Type: Article

References (28)

1. Rodríguez-Roisin R, Agustí AG, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax 1992; 47: 897-902
2. Panos RJ, Baker SK. Mediators, cytokines, and growth factors in liver-lung interactions. Clin Chest Med 1996; 17: 151-169
3. Zhang HY, Han DW, Zhao ZF, Liu MS, Wu YJ, Chen XM, Ji C. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterol 2007; 13: 3500-3507
4. Zhang J, Luo B, Tang L, Wang Y, Stockard CR, Kadish I, Van Groen T, Grizzle WE, Ponnazhagan S, Fallon MB. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology 2009; 136: 1070-1080
5. Dinh-Xuan AT, Naeije R. The hepatopulmonary syndrome: NO way out? Eur Respir J 2004; 23: 661-662
6. Palma DT, Fallon MB. The hepatopulmonary syndrome. J Hepatol 2006; 45: 617-625
7. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24: 861-880
8. Roberts DN, Arguedas MR, Fallon MB. Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates. Liver Transpl 2007; 13: 206-214
9. Møller S, Krag A, Madsen JL, Henriksen JH, Bendtsen F. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension. Liver Int 2009; 29: 1528-1537
10. Colle I, Van Steenkiste C, Geerts A, Van Vlierberghe H. Hepatopulmonary syndrome and portopulmonary hypertension: what's new? Acta Gastroenterol Belg 2007; 70: 203-209
11. Ninaber MK, de Vaal JB, Corsmit OT, Cluitmans FH, de Leeuw JG, Smit F. Severe arterial hypoxemia in liver cirrhosis. Respir Care 2009; 54: 393-397
12. Schenk P, Madl C, Rezaie-Majd S, Lehr S, Müller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000; 133: 701-706
13. Najafi Sani M, Kianifar HR, Kianee A, Khatami G. Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome. World J Gastroenterol 2006; 12: 2427-2431
14. Abrams GA, Fallon MB. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastroenterol 1998; 27: 232-235
15. Song JY, Choi JY, Ko JT, Bae EJ, Kim HS, Noh CI, Yoon YS. Long-term aspirin therapy for hepatopulmonary syndrome. Pediatrics 1996; 97: 917-920
16. Boamah L, Balistreri WF. Manifestation of liver disease. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: Saunders, 2007: 1664
17. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 1637-1648
18. Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008; 48: 465-470
19. Mahmoodi E, Kianifar HR, Partovi S, Mafinejad S, Bozorgnia A. Intrapulmonary arteriovenous shunt in children with chronic liver disease: clinical features, laboratory data and outcome. Indian J Gastroenterol 2008; 27: 16-18
20. Rodríquez-Roisin R, Krowka MJ, Hervé P, Fallon MB. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol 2005; 42: 924-927
21. Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 2365-2368
22. Austin AS, Mahida YR, Clarke D, Ryder SD, Freeman JG. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis. Aliment Pharmacol Ther 2004; 19: 79-88
23. Sztrymf B, Rabiller A, Nunes H, Savale L, Lebrec D, Le Pape A, de Montpreville V, Mazmanian M, Humbert M, Hervé P. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J 2004; 23: 752-758
24. Zhang J, Ling Y, Tang L, Luo B, Chacko BK, Patel RP, Fallon MB. Pentoxifylline attenuation of experimental hepatopulmonary syndrome. J Appl Physiol 2007; 102: 949-955
25. Tanikella R, Philips GM, Faulk DK, Kawut SM, Fallon MB. Pilot study of pentoxifylline in hepatopulmonary syndrome. Liver Transpl 2008; 14: 1199-1203
26. Gupta LB, Kumar A, Jaiswal AK, Yusuf J, Mehta V, Tyagi S, Tempe DK, Sharma BC, Sarin SK. Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study. Arch Intern Med 2008; 168: 1820-1823
27. Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr 1994; 153: 663-667
28. Windmeier C, Gressner AM. Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol 1997; 29: 181-196